See All Slides - tctmd.com

Slides

Presentation TCT 2025

High-Volume, High-Value: Optimizing LAAC Delivery Through Access Innovation

Presenter: Joseph R. Aragon

October 28, 2025

Presentation TCT 2025

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

Presenter: David Erlinge

October 28, 2025

Presentation TCT 2025

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

Presenter: Adham Ramadan

October 28, 2025

Presentation TCT 2025

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Presenter: Muhammad Zahid

October 28, 2025

Presentation TCT 2025

Surgical Intervention and CABG with use of Cangrelor

Presenter: Jennifer Rymer

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

Presenter: Robert-Jan Van Geuns

October 28, 2025

Presentation TCT 2025

Procedure Overview & Real-World Case Experience

Presenter: Mahesh Raju

October 28, 2025

Presentation TCT 2025

TCT 747: Sex and Racial Disparities in Patients Undergoing Left Atrial Appendage Closure in The United States – A Nationwide Analysis between 2018 To 2021

Presenter: Joud Fahed

October 28, 2025

Presentation TCT 2025

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Presenter: Antonin Trimaille

October 28, 2025

Advertisement

Slides

High-Volume, High-Value: Optimizing LAAC Delivery Through Access Innovation

TCT 900: Comparison of Drug-Coated Balloons and The Bioadaptor in Treatment of De Novo Coronary Lesions: A 2-Year Nationwide Analysis from SWEDEHEART

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Surgical Intervention and CABG with use of Cangrelor

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

TCT 245: Final 7-Year Results from the COMPARE-ABSORB Trial: Randomized Comparison of Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis. Detailed analysis of long lesions

Procedure Overview & Real-World Case Experience

TCT 747: Sex and Racial Disparities in Patients Undergoing Left Atrial Appendage Closure in The United States – A Nationwide Analysis between 2018 To 2021

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content